Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.89B
Revenue (ttm)	235.22M
Net Income (ttm)	10.08M
Shares Out	2.40M
EPS (ttm)	4.20
PE Ratio	187.31
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	n/a

Volume	6,022
Average Volume	2,097
Open	n/a
Previous Close	774.20
Day's Range	780.10 - 829.00
52-Week Range	675.00 - 947.90
Beta	-0.39
RSI	41.84
Earnings Date	Oct 30, 2025

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal, anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid dr...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 529
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In 2024, Ambee Pharmaceuticals's revenue was 219.30 million, an increase of 10.71% compared to the previous year's 198.10 million. Earnings were 9.68 million, an increase of 6.53%.